Cancer/ News/ Patients/ R&D Accord’s biosimilar Pelgraz poised for approval Joy Persaud Accord Healthcare, cancer, market access, Oncology, Pelgraz 0 Comment Cancer biosimilar drug Pelgraz is poised to hit the market after receiving a positive opinion by the Committee Share X Accord’s biosimilar Pelgraz poised for approval https://pharmaphorum.com/cancer/accords-biosimilar-pelgraz-poised-for-approval/
Accord Healthcare, cancer, market access, Oncology, Pelgraz
0 Comment
